Prevalence of Thyroid Dysfunction in Pregnant Women and Its Association with Adverse Pregnancy Outcomes
International Journal of Current Pharmaceutical Review and Research · 13.05.2026 · 18 (04)
DOI: 10.25258/ijcpr.18.4.223 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 13.05.2026. Verfasst von Rashmi Sinha und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Diagnosing thyroid problems during pregnancy is quite common within the endocrine system. There are the physiological changes in pregnancy which can uncover the physiological changes of the thyroid. If these changes are not diagnosed or managed correctly, they can cause problems for the mother or fetus. Even though the problems are very important, the issues are not being diagnosed correctly because there are not routine or standardized screenings.
Objectives
Evaluate the rate of thyroid dysfunction adverse outcomes of pregnancy among women attending outpatient department of Obstetrics & Gynecology at JLNMCH, Bhagalpur.
Methods
Over a period of one year from 1st Nov 2023 to 31st Oct 2024 and a follow-up of 6 months, the study was carried out at Outpatient department of Obstetrics & Gynecology JLNMCH Bhagalpur and was aimed at one hundred pregnant women. All the participants had their serum thyroid-stimulating hormone (TSH) levels measured and, where necessary, free thyroxine (FT4) and free triiodothyronine (FT3) levels assessed. Depending on the results of the participants’ thyroid function tests, the participants were classified as either euthyroid, subclinical hypothyroid, overt hypothyroid, and hyperthyroid. Maternal and fetal outcomes were tracked until delivery. Descriptive statistics and either Chi-square or Fisher’s exact tests were employed for the statistical analysis, with a significance level of less than 0.05.
Results
Eighteen percent of participants were found to have thyroid dysfunction. The most prevalent of these was subclinical hypothyroidism at 14%, while overt hypothyroidism was at 3%, and hyperthyroidism at 1%. There were higher rates of adverse maternal outcomes (preeclampsia, gestational hypertension, anemia, and abortion) among women with thyroid dysfunction. This group also had significantly higher rates of fetal complications (preterm birth, low birth weight, low APGAR scores, and increased NICU admissions).
Conclusion
Pregnant women are at increased risk for thyroid dysfunction which adversely impacts both maternal and fetal health. To enhance perinatal outcomes, it is important to implement systematic screening and introduce treatment as early as possible during the course of the pregnancy.
Zitieren
APA
Sinha, R., Sinha, A., & Kumari, S. (2026). Prevalence of Thyroid Dysfunction in Pregnant Women and Its Association with Adverse Pregnancy Outcomes. International Journal of Current Pharmaceutical Review and Research, 18(04). https://doi.org/10.25258/ijcpr.18.4.223
Vancouver
Sinha R, Sinha A, Kumari S. Prevalence of Thyroid Dysfunction in Pregnant Women and Its Association with Adverse Pregnancy Outcomes. International Journal of Current Pharmaceutical Review and Research. 2026;18(04). doi:10.25258/ijcpr.18.4.223
BibTeX
@article{Sinha2026,
author = {Sinha, Rashmi and Sinha, Anupama and Kumari, Sheela},
title = {Prevalence of Thyroid Dysfunction in Pregnant Women and Its Association with Adverse Pregnancy Outcomes},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {04},
doi = {10.25258/ijcpr.18.4.223}
}
EUVIMED